Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon

Histology and Histopathology

Volumn 22, Issue 1-3, 2007, Pages 251-260

  Mizoshita, T ^a   Tsukamoto, Tetsuya ^a   Inada, K I ^a,b   Hirano, N ^a   Tajika, M ^a   Nakamura, T ^a   Ban, H ^a   Tatematsu, M ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cdx2; Colorectal adenomas; Colorectal carcinomas; MUC2; MUC5AC

Indexed keywords

MUCIN 2; MUCIN 5AC; TRANSCRIPTION FACTOR CDX2;

ARTICLE; CANCER INVASION; COLON ADENOMA; COLON CARCINOGENESIS; COLON CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PHENOTYPE; PROTEIN EXPRESSION; STOMACH;

ADENOCARCINOMA; ADENOMA, VILLOUS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROFILAMENT PROTEINS; MUCINS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846282337     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Ajioka Y., Allison L.J. and Jass J.R. (1996). Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J. Clin. Pathol. 49, 560-564.
2. Ajioka Y., Watanabe H. and Jass J.R. (1997). MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas. J. Clin. Pathol. 50, 417-421.
3. Almeida R., Silva E., Santos-Silva F., Silberg D.G., Wang J., De Bolos C. and David L. (2003). Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J. Pathol. 199, 36-40.
4. Aoki K., Tamai Y., Horiike S., Oshima M. and Taketo M.M. (2003). Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/ Delta716 Cdx2+/- compound mutant mice. Nat. Genet. 35, 323-330.
5. Bai Y.Q., Miyake S., Iwai T. and Yuasa Y. (2003). CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene. Oncogene 22, 7942-7949.
6. Baldus S.E., Monig S.P., Arkenau V., Hanisch F.G., Schneider P.M., Thiele J., Holscher A.H. and Dienes H.P. (2002). Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma. Ann. Surg. Oncol. 9, 887-893.
7. Bara J., Languille O., Gendron M.C., Daher N., Martin E. and Burtin P. (1983). Immunohistological study of precancerous mucus modification in human distal colonic polyps. Cancer Res. 43, 3885-3891.
8. Bara J., Chastre E., Mahiou J., Singh R.L., Forgue-Lafitte M.E., Hollande E. and Godeau F. (1998). Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int. J. Cancer 75, 767-773.
9. Bartman A.E., Sanderson S.J., Ewing S.L., Niehans G.A., Wiehr C.L., Evans M.K. and Ho S.B. (1999). Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int. J. Cancer 80, 210-218.
10. Biemer-Huttmann A.E., Walsh M.D., McGuckin M.A., Ajioka Y., Watanabe H., Leggett B.A. and Jass J.R. (1999). Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J. Histochem. Cytochem. 47, 1039-1048.
11. Biemer-Huttmann A.E., Walsh M.D., McGuckin M.A., Simms L.A., Young J., Leggett B.A. and Jass J.R. (2000). Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin. Cancer Res. 6, 1909-1916.
12. Blank M., Klussmann E., Kruger-Krasagakes S., Schmitt-Graff A., Stolte M., Bornhoeft G., Stein H., Xing P.X., McKenzie I.F., Verstijnen C.P., Riecken E.O. and Hanski C. (1994). Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int. J. Cancer 59, 301-306.
13. Bonhomme C., Duluc I., Martin E., Chawengsaksophak K., Chenard M.P., Kedinger M., Beck F., Freund J.N. and Domon-Dell C. (2003). The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 52, 1465-1471.
14. Buisine M.P., Janin A., Maunoury V., Audie J.P., Delescaut M.P., Copin M.C., Colombel J.F., Degand P., Aubert J.P. and Porchet N. (1996). Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology 110, 84-91.
15. Chang S.K., Dohrman A.F., Basbaum C.B., Ho S.B., Tsuda T., Toribara N.W., Gum J.R. and Kim Y.S. (1994). Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 107, 28-36.
16. Ee H.C., Erler T., Bhathal P.S., Young G.P. and James R.J. (1995). Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am. J. Pathol. 147, 586-592.
17. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M. and Kolodner R. (1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027-1038.
18. Hansel D.E., Maitra A., Lin J.W., Goggins M., Argani P., Yeo C.J., Piantadosi S., Leach S.D. and Biankin A.V. (2005). Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. J. Clin. Oncol. 23, 1811-1818.
19. Hanski C., Riede E., Gratchev A., Foss H.D., Bohm C., Klussmann E., Hummel M., Mann B., Buhr H.J., Stein H., Kim Y.S., Gum J. and Riecken E.O. (1997). MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA, methylation. Lab. Invest. 77, 685-695.
20. Hirono H., Ajioka Y., Watanabe H., Baba Y., Tozawa E., Nishikura K., Mukai G., Honma T. and Aoyagi Y. (2004). Bidirectional gastric differentiation in cellular mucin phenotype (foveolar and pyloric) in serrated adenoma and hyperplastic polyp of the colorectum. Pathol. Int. 54, 401-407.
21. Iwase T., Kushima R., Mukaisho K., Mitsufuji S., Okanoue T. and Hattori T. (2005). Overexpression of CD10 and reduced MUC2 expression correlate with the development and progression of colorectal neoplasms. Pathol. Res. Pract. 201, 83-91.
22. Japanese Society for Cancer of the Colon and Rectum (1998). General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum, and Anus, 6th edn. Tokyo: Kanehara.
23. Jass J.R. (1999). Serrated adenoma and colorectal cancer. J. Pathol. 187, 499-502.
24. Jass J.R. and Walsh M.D. (2001). Altered mucin expression in the gastrointestinal tract: a review. J. Cell. Mol. Med. 5, 327-351.
25. Koike M., Inada K., Nakanishi H., Matsuura A., Nakamura S. and Tatematsu M. (2003). Cellular differentiation status of epithelial polyps of the colorectum: the gastric foveolar cell-type in hyperplastic polyps. Histopathology 42, 357-364.
26. Kudo S., Kashida H., Nakajima T., Tamura S. and Nakajo K. (1997). Endoscopic diagnosis and treatment of early colorectal cancer. World. J. Surg. 21, 694-701.
27. Kuramoto S. and Oohara T. (1988). Minute cancers arising de novo in the human large intestine. Cancer 61, 829-834.
28. Longman R.J., Douthwaite J., Sylvester P.A., O'Leary D., Warren B.F., Corfield A.P. and Thomas M.G. (2000). Lack of mucin MUC5AC field change expression associated with tubulovillous and villous colorectal adenomas. J. Clin. Pathol. 53, 100-104.
29. Mallo G.V., Rechreche H., Frigerio J.M., Rocha D., Zweibaum A., Lacasa M., Jordan B.R., Dusetti N.J., Dagorn J.C. and Iovanna J.L. (1997). Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int. J. Cancer 74, 35-44.
30. Mallo G.V., Soubeyran P., Lissitzky J.C., Andre F., Farnarier C., Marvaldi J., Dagorn J.C. and Iovanna J.L. (1998). Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J. Biol. Chem. 273, 14030-14036.
31. Matsumoto K., Mizoshita T., Tsukamoto T., Ogasawara N., Hirata A., Shimizu Y., Haneda M., Yamao K. and Tatematsu M. (2004). Cdx2 expression in pancreatic tumors: Relationship with prognosis of invasive ductal carcinomas. Oncol. Rep. 12, 1239-1243.
32. Mizoshita T., Inada K., Tsukamoto T., Kodera Y., Yamamura Y., Hirai T., Kato T., Joh T., Itoh M. and Tatematsu M. (2001). Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa--with special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 4, 185-191.
33. Mizoshita T., Tsukamoto T., Nakanishi H., Inada K., Ogasawara N., Joh T., Itoh M., Yamamura Y. and Tatematsu M. (2003). Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J. Cancer Res. Clin. Oncol. 129, 727-734.
34. Mizoshita T., Inada K., Tsukamoto T., Nozaki K., Joh T., Itoh M., Yamamura Y., Ushijima T., Nakamura S. and Tatematsu M. (2004a). Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J. Cancer Res. Clin. Oncol. 130, 29-36.
35. Mizoshita T., Tsukamoto T., Inada K., Ogasawara N., Hirata A., Kato S., Joh T., Itoh M., Yamamura Y. and Tatematsu M. (2004b). Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol. Int. 54, 392-400.
36. Mizoshita T., Tsukamoto T., Cao X., Otsuka T., Ito S., Takahashi E., Nakamura S., Nakamura T., Yamamura Y. and Tatematsu M. (2005a). Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype. Gastric Cancer 8, 164-172.
37. Mizoshita T., Tsukamoto T., Tanaka H., Takenaka Y., Kato S., Cao X., Joh T. and Tatematsu M. (2005b). Colonic and small-intestinal phenotypes in gastric cancers: Relationships with clinicopathological findings. Pathol. Int. 55, 611-618.
38. Muto T., Kamiya J., Sawada T., Konishi F., Sugihara K., Kubota Y., Adachi M., Agawa S., Saito Y., Morioka Y. and Tanprayoon T. (1985). Small "flat adenoma" of the large bowel with special reference to its clinicopathologic features. Dis. Colon Rectum. 28, 847-851.
39. Myerscough N., Sylvester P.A., Warren B.F., Biddolph S., Durdey P., Thomas M.G., Carlstedt I. and Corfield A.P. (2001). Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide. Glycoconj. J. 18, 907-914.
40. Ookawa K., Kudo T., Aizawa S., Saito H. and Tsuchida S. (2002). Transcriptional activation of the MUC2 gene by p53. J. Biol. Chem. 277, 48270-48275.
41. Reis C.A., David L., Nielsen P.A., Clausen H., Mirgorodskaya K., Roepstorff P. and Sobrinho-Simoes M. (1997). Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int. J. Cancer 74, 112-121.
42. Reis C.A., David L., Correa P., Carneiro F., de Bolos C., Garcia E., Mandel U., Clausen H. and Sobrinho-Simoes M. (1999). Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 59, 1003-1007.
43. Reis C.A., David L., Carvalho F., Mandel U., de Bolos C., Mirgorodskaya E., Clausen H. and Sobrinho-Simoes M. (2000). Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J. Histochem. Cytochem. 48, 377-388.
44. Senba S., Konishi F., Okamoto T., Kashiwagi H., Kanazawa K., Miyaki M., Konishi M. and Tsukamoto T. (1998). Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors. Cancer 82, 279-285.
45. Sessa F., Bonato M., Frigerio B., Capella C., Solcia E., Prat M., Bara J. and Samloff I.M. (1990). Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 98, 1655-1665.
46. Shimoda T., Ikegami M., Fujisaki J., Matsui T., Aizawa S. and Ishikawa E. (1989). Early colorectal carcinoma with special reference to its development de novo. Cancer 64, 1138-1146.
47. Silberg D.G., Swain G.P., Suh E.R. and Traber P.G. (2000). Cdx1 and cdx2 expression during intestinal development. Gastroenterology 119, 961-971.
48. Sylvester P.A., Myerscough N., Warren B.F., Carlstedt I., Corfield A.P., Durdey P. and Thomas M.G. (2001). Differential expression of the chromosome 11 mucin genes in colorectal cancer. J. Pathol. 195, 327-335.
49. Tajima Y., Shimoda T., Nakanishi Y., Yokoyama N., Tanaka T., Shimizu K., Saito T., Kawamura M., Kusano M. and Kumagai K. (2001). Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 61, 212-220.
50. Takata M., Yao T., Nishiyama K.I., Nawata H. and Tsuneyoshi M. (2003). Phenotypic alteration in malignant transformation of colonic villous tumours: with special reference to a comparison with tubular tumours. Histopathology 43, 332-339.
51. Tatematsu M., Tsukamoto T. and Inada K. (2003). Stem cells and gastric cancer-Role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci. 94, 135-141.
52. Tsukamoto T., Inada K., Tanaka H., Mizoshita T., Mihara M., Ushijima T., Yamamura Y., Nakamura S. and Tatematsu M. (2004). Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J. Cancer. Res. Clin. Oncol. 130, 135-145.
53. Tsukamoto T., Mizoshita T., Mihara M., Tanaka H., Takenaka Y., Yamamura Y., Nakamura S., Ushijima T. and Tatematsu M. (2005). Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 46, 649-658.
54. Velcich A., Yang W., Heyer J., Fragale A., Nicholas C., Viani S., Kucherlapati R., Lipkin M., Yang K. and Augenlicht L. (2002). Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295, 1726-1729.
55. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M. and Bos J.L. (1988). Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532.
56. Welch J.S. and Dockerty M.B. (1958). Villous carcinoma of the colon. Dis. Colon Rectum 1, 251-261.
57. Yamamoto H., Bai Y.Q. and Yuasa Y. (2003). Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem. Biophys. Res. Commun. 300, 813-818.
58. Yao T., Kouzuki T., Kajiwara M., Matsui N., Oya M. and Tsuneyoshi M. (1999). 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential. J. Pathol. 187, 511-517.
59. Yao T., Tsutsumi S., Akaiwa Y., Takata M., Nishiyama K., Kabashima A. and Tsuneyoshi M. (2001). Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn. J. Cancer Res. 92, 755-761.
60. Yao T., Takata M., Tustsumi S., Nishiyama K., Taguchi K., Nagai E. and Tsuneyoshi M. (2002). Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis. Pathology 34, 556-560.